IncFact
Company Profiles: Revenue, Growth, Competition

BIOVERATIV Revenue, Growth & Competitor Profile

DBA BIOVERATIV THERAPEUTICS, INC.
DBA BIOVERATIV U.S. LLC.
Last updated:

Company Awards

Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Bioverativ

Access the complete profile.

Bioverativ Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
5417 Scientific Research & Development Services
541714
Address225 2nd Ave
Waltham, MA 02451

www.sanofi.com
Note: Revenues for privately held companies are statistical evaluations.


Bioverativ's annual revenues are over $500 million (see exact revenue data). It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Bioverativ's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Bioverativ Annual Revenue and Growth Rate

Bioverativ Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Bioverativ's revenues are gauged from an analysis of company filings.



Bioverativ's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Bioverativ Revenue (Sales) Bioverativ Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Bioverativ is developing and marketing. Bioverativ's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
GIVJOVA
Pharmaceutical product to treat cold agglutinin disease (CAgD)
01/09/2019
ENJAYMO
Pharmaceutical product to treat cold agglutinin disease (CAgD)
01/09/2019

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Bioverativ grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Bioverativ is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Bioverativ's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bioverativ, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
TMUNITY THERAPEUTICSPhiladelphia, PA100 
PANACEA BIOMATXResearch Triangle Park, NC52 




Nearby Competitors

These companies are similar in business line and location to Bioverativ. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
BIOGEN U.S.Weston, MA100 
SHIRE HOLDINGS US AGLexington, MA73 
CUBIST PHARMACEUTICALSLexington, MA7 
BIOVERATIVWaltham, MA7 
AMAG PHARMACEUTICALSWaltham, MA4 
REPLIGENWaltham, MA1 




Future Competition: Bioverativ's Fastest Growing Competitors

These companies are in the same general field as Bioverativ and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Bioverativ Competitors